TAM
EVFM

Tiverton Asset Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Tiverton Asset Management’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-9,444
Closed -$6.36M – 138
2014
Q4 		$6.36M Buy
+9,444
New +$7.13M 0.13% 111

Other funds holding EVFM

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
PSC
Piper Sandler & Co Minneapolis, Minnesota $102M AUM 0.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
NIP
Nicholas Investment Partners Rancho Santa Fe, California $1.39B AUM 97.11% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Tiverton Asset Management's EVFM Position: Q1 2015 in Review

Tiverton Asset Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q1 2015, closing a stake of 9,444 shares — an estimated $6.36M sold.

Tiverton Asset Management first reported a position in EVFM in Q4 2014 and held it in 1 quarter. The position peaked at $6.36M in Q4 2014. 21 funds tracked by Wall St. Rank hold EVFM as of Q1 2015.

  • Tiverton Asset Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Tiverton Asset Management sold 9,444 Evofem Biosciences, Inc. Common Stock shares in Q1 2015, an estimated $6.36M.
  • Tiverton Asset Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2014 and held it in 1 quarter.
  • Tiverton Asset Management's Evofem Biosciences, Inc. Common Stock position peaked at $6.36M in Q4 2014.
  • 21 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q1 2015.

Based on Tiverton Asset Management's 13F filing for Q1 2015, filed 12 May 2015.